Premium
Combining QUANTICYT karyometric analysis with architectural confocal‐aided cytology to prognosticate superficial bladder cancer
Author(s) -
Boon Mathilde E.,
Marres Elisabeth M.,
van der Poel H. G.
Publication year - 1998
Publication title -
diagnostic cytopathology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.417
H-Index - 65
eISSN - 1097-0339
pISSN - 8755-1039
DOI - 10.1002/(sici)1097-0339(199801)18:1<10::aid-dc3>3.0.co;2-y
Subject(s) - medicine , cytology , confocal , grading (engineering) , feulgen stain , pathology , confocal microscopy , bladder cancer , stain , radiology , cancer , staining , biology , ecology , geometry , mathematics , microbiology and biotechnology
For this study, bladder washings of 923 patients with a follow‐up for superficial bladder cancer were used. For the prognostication of each case (follow‐up period up to 20 mo), two parameters were used: tumor recurrence and the event of (progressing) invasive growth. Each sample was classified as negative, low grade or high grade, based on confocal‐aided architectural cytology. The feature architecture was based on the images of the epithelial fragments as seen in the Feulgen stain, which also could be visualized in confocal microscopy. The same three classes were also used for grading the samples according to the QUANTICYT system, in which DNA and morphometry of nuclei were automatically assessed. The 532 cases graded as QUANTICYT high had a worse prognosis than the 391 cases with QUANTICYT low. In addition, architectural cytology contributed significantly for the prognostication of cases classified as QUANTICYT high, the 228 nonconcording cases faring better than the 304 concording ones. For QUANTICYT low, the 156 nonconcording cases had also a lower recurrence rate than the 235 concording ones, but this difference was only significant in patients followed for up to 8 mo. These findings indicate that QUANTICYT grading supplemented by architectural cytology supplies the clinician with valuable prognostic information which can be used to limit cystoscopies. Diagn. Cytopathol. 1998;18:10–17. © 1998 Wiley‐Liss, Inc.